Change language dansk English suomi svenska

Generate Estimates Confirm Cancel Hide empty rows Show hidden rows DummyText

PARK BIO ApS Estimate generation in progress, please wait... 0%

Quicksearch from your own companies XBRLDenmark Analyst: XBRLDenmark

Loading... Loading... Loading... Loading... Loading... Loading... Loading...

1000.0 Bankruptcy Risk  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Bankruptcy risk for industry   1.5% 1.5% 1.5% 1.5% 1.5% 1.5% 2.8% 2.8%   Bankruptcy risk   13.6% 18.1% 4.4% 2.5% 9.1% 7.8% 12.1% 11.8%   Credit score (0-100)   18 9 47 61 26 30 20 20   Credit rating   BB B BBB BBB BB BB BB BB   Credit limit (kDKK)   0.0 0.0 0.0 0.0 -0.0 0.0 0.0 0.0   How are these values calculated?   View the automatically generated explanation of bankruptcy risk 1000.0 Income statement (kDKK)  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   3,577 3,571 0 0 0 0 0 0   Gross profit   1,329 1,485 884 952 413 116 0.0 0.0   EBITDA   1,624 1,752 176 258 -457 -856 0.0 0.0   EBIT   1,440 1,607 96.6 179 -508 -935 0.0 0.0   Pre-tax profit (PTP)   -230.0 65.0 75.4 174.3 -521.1 -959.5 0.0 0.0   Net earnings   -233.0 65.0 75.4 193.0 -406.7 -747.8 0.0 0.0   Pre-tax profit without non-rec. items   1,411 1,581 75.4 174 -521 -960 0.0 0.0     See the entire income statement 1000.0 Balance sheet (kDKK)  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Tangible assets total   545 381 302 223 144 64.6 0.0 0.0   Shareholders equity total   92.0 157 233 426 19.0 619 494 494   Interest-bearing liabilities   469 177 90.9 30.3 263 1.6 0.0 0.0   Balance sheet total (assets)   1,174 870 872 1,197 640 1,075 494 494   Net Debt   291 101 -128 -575 260 -486 -494 -494     See the entire balance sheet 1000.0 Volume  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   3,577 3,571 0 0 0 0 0 0   Net sales growth   -1.4% -0.2% -100.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Gross profit   1,329 1,485 884 952 413 116 0.0 0.0   Gross profit growth   11.8% 11.7% -40.5% 7.7% -56.6% -72.0% -100.0% 0.0%   Employees   0 0 3 3 4 4 0 0   Employee growth %   0.0% 0.0% 0.0% 0.0% 33.3% 0.0% -100.0% 0.0%   Employee expenses   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   1,174 870 872 1,197 640 1,075 494 494   Balance sheet change%   -7.7% -25.9% 0.2% 37.3% -46.5% 67.9% -54.0% 0.0%   Added value   1,624.0 1,752.0 175.8 258.2 -429.0 -855.6 0.0 0.0   Added value %   45.4% 49.1% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Investments   -386 -309 -158 -158 -130 -158 -65 0   Net sales trend   -2.0 -3.0 -4.0 0.0 0.0 0.0 0.0 0.0   EBIT trend   3.0 4.0 5.0 5.0 -1.0 -2.0 0.0 0.0   1000.0 Profitability  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A EBITDA %   45.4% 49.1% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT %   40.3% 45.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT to gross profit (%)   108.4% 108.2% 10.9% 18.8% -122.9% -808.2% 0.0% 0.0%   Net Earnings %   -6.5% 1.8% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Profit before depreciation and extraordinary items %   -1.4% 5.9% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Pre tax profit less extraordinaries %   39.4% 44.3% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   ROA %   117.7% 157.2% 11.1% 17.3% -55.3% -109.0% 0.0% 0.0%   ROI %   272.2% 359.1% 29.4% 46.0% -137.8% -207.2% 0.0% 0.0%   ROE %   -111.8% 52.2% 38.7% 58.6% -182.9% -234.4% 0.0% 0.0%   1000.0 Solidity  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Equity ratio %   7.8% 18.0% 27.2% 35.6% 3.0% 57.6% 100.0% 100.0%   Relative indebtedness %   30.2% 20.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Relative net indebtedness %   25.3% 17.8% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net int. bear. debt to EBITDA, %   17.9% 5.8% -72.6% -222.5% -56.9% 56.8% 0.0% 0.0%   Gearing %   509.8% 112.7% 39.1% 7.1% 1,380.5% 0.3% 0.0% 0.0%   Net interest   0 0 0 0 0 0 0 0   Financing costs %   9.0% 8.0% 15.9% 8.3% 8.9% 18.7% 0.0% 0.0%   1000.0 Liquidity  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Quick Ratio   0.4 0.4 0.7 1.1 0.6 2.0 0.0 0.0   Current Ratio   0.5 0.6 0.7 1.1 0.6 2.1 0.0 0.0   Cash and cash equivalent   178.0 76.0 218.6 604.8 2.6 487.3 0.0 0.0   1000.0 Capital use efficiency  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Trade debtors turnover (days)   25.9 19.8 0.0 0.0 0.0 0.0 0.0 0.0   Trade creditors turnover (days)   969.0 615.7 0.0 0.0 0.0 0.0 0.0 0.0   Current assets / Net sales %   15.0% 11.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net working capital   -544.0 -319.0 -167.4 104.7 -222.8 496.1 0.0 0.0   Net working capital %   -15.2% -8.9% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Employee efficiency  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales / employee   0 0 0 0 0 0 0 0   Added value / employee   0 0 59 86 -107 -214 0 0   Employee expenses / employee   0 0 0 0 0 0 0 0   EBITDA / employee   0 0 59 86 -114 -214 0 0   EBIT / employee   0 0 32 60 -127 -234 0 0   Net earnings / employee   0 0 25 64 -102 -187 0 0